Free Trial
CVE:ROI

Route1 (ROI) Stock Price, News & Analysis

Route1 logo
C$0.10 +0.03 (+31.25%)
As of 09/8/2025 05:40 PM Eastern

About Route1 Stock (CVE:ROI)

Key Stats

Today's Range
C$0.07
C$0.14
50-Day Range
C$0.05
C$0.11
52-Week Range
C$0.02
C$0.14
Volume
184,850 shs
Average Volume
36,644 shs
Market Capitalization
C$4.46 million
P/E Ratio
N/A
Dividend Yield
2.66%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ROI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Route1 and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ROI Stock News Headlines

Route1 (CVE:ROI) Trading 23.1% Higher - Still a Buy?
Route1 (CVE:ROI) Stock Price Up 23.1% - What's Next?
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.tc pixel
Route1 (CVE:ROI) Shares Up 23.1% - What's Next?
Route1 (CVE:ROI) Stock Price Up 23.1% - Should You Buy?
Route1 (CVE:ROI) Stock Price Up 23.1% - Here's Why
Route1 (CVE:ROI) Trading 23.1% Higher - What's Next?
Route1 (CVE:ROI) Trading 23.1% Higher - Time to Buy?
See More Headlines

ROI Stock Analysis - Frequently Asked Questions

Route1's stock was trading at C$0.05 on January 1st, 2025. Since then, ROI shares have increased by 110.0% and is now trading at C$0.11.

Shares of ROI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Route1 investors own include Converge Technology Solutions (CTS), Facedrive (FDVRF), kneat.com (KSI), Ackroo (AKR), Aecon Group (ARE), BeWhere (BEW) and BlueRush (BTV).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Software - Application
Sub-Industry
N/A
Current Symbol
CVE:ROI
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
10.50
P/E Growth
N/A
Net Income
-C$1.13 million
Net Margins
-5.09%
Pretax Margin
N/A
Return on Equity
-169.05%
Return on Assets
-2.99%

Debt

Debt-to-Equity Ratio
8,864.92
Current Ratio
0.31
Quick Ratio
0.44

Sales & Book Value

Annual Sales
C$13.56 million
Price / Sales
0.33
Cash Flow
C$0.01 per share
Price / Cash Flow
16.67
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
42,497,000
Free Float
N/A
Market Cap
C$4.46 million
Optionable
Not Optionable
Beta
-0.04
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (CVE:ROI) was last updated on 9/9/2025 by MarketBeat.com Staff
From Our Partners